Atlanta, GA, April 29, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its existing contract with a 1,250 bed, Epic-based academic medical center serving central Florida. The health system recently completed its initial implementation of eValuator and has elected to expand its utilization to include additional acquired facilities.
Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator’s AI-enhanced pre-bill code auditing ensures that providers can accurately capture, bill and ultimately be paid for all the care they provide, while avoiding denials.
“We are thrilled to grow alongside our client so quickly following their eValuator go-live” stated Ben Stilwill, President and Chief Executive Officer, Streamline. “Within a month of go-live our client saw significant ROI, partially driven by our new AI-generated rules. As a result of their experience with Streamline Health’s powerful solution and dedicated team members, the client quickly expanded utilization of eValuator to their new facilities to have a unified platform across the system.”
About Streamline Health
Streamline Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance. We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. For more information, visit www.streamlinehealth.net
Contact
Jacob Goldberger
Vice President of Finance
303.887.9625
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$3.52 |
Daily Change: | -0.10 -2.63 |
Daily Volume: | 8,468 |
Market Cap: | US$15.010M |
December 18, 2024 December 16, 2024 October 08, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load